Fulgent Genetics Inc.
Case Overview
| Status: | Status: Investigating |
| Company Name: | Company Name: Fulgent Genetics Inc. |
| Ticker: | Ticker: FLGT |
| Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
| Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP is investigating potential claims against Fulgent Genetics Inc. (“Fulgent” or the “Company”) (NASDAQ:FLGT). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.
On February 27, 2026, Fulgent issued a press release reporting its fourth quarter and full year 2025 financial results. Among other items, Fulgent provided lower-than-expected guidance for 2026, “reflect[ing] the impact of [its] largest customer moving a significant volume of its work in-house[.]” On this news, the price of Fulgent shares declined by $9.43 per share, or approximately 38.1%, from $24.76 per share on February 26, 2026 to close at $15.33 on February 27, 2026.
On February 27, 2026, Fulgent issued a press release reporting its fourth quarter and full year 2025 financial results. Among other items, Fulgent provided lower-than-expected guidance for 2026, “reflect[ing] the impact of [its] largest customer moving a significant volume of its work in-house[.]” On this news, the price of Fulgent shares declined by $9.43 per share, or approximately 38.1%, from $24.76 per share on February 26, 2026 to close at $15.33 on February 27, 2026.